Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

8,064 public trials 719 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Recruiting

Swiss Diabetes Registry - SwissDiab Study

NCT01179815

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations
  • Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern Bern, Switzerland
  • Service d'endocrinologie, diabétologie et métabolisme Lausanne, Switzerland
  • Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen Sankt Gallen, Switzerland
  • Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich Zurich, Switzerland
View Trial Details
Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

NCT07632677

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations
  • Department of Endocrinology, the First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Department of Endocrinology, the Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Department of Endocrinology, the Second Affiliated Hospital of Wannan Medical University Wuhu, Anhui, China
  • Department of Endocrinology, Zhujiang Hospital, Southern Medical University Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Recruiting

A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

NCT07303803

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
Locations
  • Ditan Hospital of integrated traditional Chinese and Western Medicine Center Beijing, Beijing Municipality, China
  • Southwest Hospital of Third Military Medical University Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View all 17 locations
View Trial Details
Recruiting

Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin

NCT07621419

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Hospital General de Agudos Dr Enrique Tornú Buenos Aires, Argentina
View Trial Details

Related conditions